The global GLP-1 targeted peptide weight loss drugs market size was calculated at USD 61.18 billion in 2024 and is expected to reach USD 193.44 billion by 2034, expanding at a CAGR of 12.2% between 2025 and 2034
Ongoing support Get access to Shed Health Coaching, unlimited provider follow-ups, step-by-step health courses, and more.* Start your weight-loss journey with Wegovy Start your weight-loss journey with Wegovy Supports healthy metabolic function* Supports weight management* *This information is for educational purposes only and is not a substitute for professional medical advice
Which companies are affected
Reducing Inflammation : GHK-Cu lowers harmful inflammatory cytokines and boosts factors that fight inflammation, creating the best conditions for healing
Novel devices and applications for diagnosing obstructive sleep apnea
Programmed cell death protein-1 (PD-1), programmed death ligand-1 (PD-L1) and cytotoxic T lymphocyte-associated protein 4 (CTLA-4) signaling represent the most prominent and well-studied immune checkpoints